NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

Hi Antihama,
The discussion has followed from an announcement on the FDA's website:

On the FDA's website it is stated that the FDA and the MHRA have been considering expanding the scope of the MRA to include vaccines and plasma-derived pharmaceuticals for human use which will be considered again in July 2025 based on further assessment.

. I suggested that in the course of garnering all the information needed for the July 2025 discussion, the FDA might be given sight (perhaps unofficially) of all the data held by the MHRA thus shortening the length of time for the FDA to come to a decision once NWBO submitted DCVax-L to them for approval.